EW vs. FMS: Edwards Lifesciences vs. Fresenius Medical Care Stock Comparison

Company Profile

Edwards Lifesciences (EW) and Fresenius Medical Care (FMS) both fall under the Health Care Equipment & Services industry group, but EW is classified in Health Care Equipment & Supplies while FMS is classified in Health Care Providers & Services.

Edwards Lifesciences (EW) trades as ordinary local shares, while Fresenius Medical Care (FMS) trades as an ADR — compare with FX exposure, depositary-program fees, and dividend-withholding-tax differences in mind.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Both Edwards Lifesciences (EW) at 9.33% and Fresenius Medical Care (FMS) at 7.84% land near their industries’ usual ROE ranges, so capital efficiency looks broadly in line with peers on both sides.

Edwards Lifesciences (EW) at 15.30% retains a top-quartile share of revenue as profit, ahead of Fresenius Medical Care (FMS) at 4.22%, which keeps about the industry-typical share.

Edwards Lifesciences (EW) at 30.15% operates in the top operating margin quartile, ahead of Fresenius Medical Care (FMS) at 9.63%, which runs around its industry’s norm.

Profitability Metrics

Growth

Edwards Lifesciences (EW) at 11.55% is around its peer norm for revenue growth, while Fresenius Medical Care (FMS) at 1.51% drops into the bottom quartile, signaling weaker demand or pricing momentum.

Fresenius Medical Care (FMS) at 83.61% sits in the top EPS growth quartile, while Edwards Lifesciences (EW) at -73.74% is in the bottom quartile, showing a clear gap in earnings momentum.

Growth Metrics

Financial Strength

Edwards Lifesciences (EW) at 4.60 carries current ratio above its industry’s typical mid-range, while Fresenius Medical Care (FMS) at 0.99 runs in the tighter-liquidity quartile — different working-capital profiles, both worth examining.

Edwards Lifesciences (EW) at 0.06 keeps leverage in the lower industry quartile, while Fresenius Medical Care (FMS) at 0.79 runs a more typical debt-to-equity mix.

Financial Strength Metrics

Dividends

Edwards Lifesciences (EW) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Fresenius Medical Care (FMS) reports a yield of 6.30%, ranking against industry peers normally.

Edwards Lifesciences (EW) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Fresenius Medical Care (FMS) reports a payout of 50.14%, ranking against industry peers normally.

Dividend Metrics

Valuation

Fresenius Medical Care (FMS) at 13.53 sits in the cheaper P/E ratio quartile, while Edwards Lifesciences (EW) at 59.38 sits in the richer quartile — a clear split in what investors pay for each dollar of trailing earnings.

Fresenius Medical Care (FMS) at 0.62 looks cheap on sales in the lower P/S ratio quartile, while Edwards Lifesciences (EW) at 8.80 looks rich in the upper quartile — a clear gap in price per dollar of revenue.

Fresenius Medical Care (FMS) at 0.85 sits in the lower P/B ratio quartile against book while Edwards Lifesciences (EW) at 5.41 is valued near its industry’s middle — FMS is cheaper on assets, though weigh it against ROE and asset quality.

Valuation Metrics